NARI insider transaction filings

Inari Medical, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-02-19. Screen NARI transaction legs live →

Insider transaction summary — last 90 days

No Form 4 filings for NARI between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.

Recent Form 4 filings — Inari Medical, Inc.

FiledFormInsiderReported transactionsSource
2025-02-194Warner Robert Keith — DirectorCode (U): 12,149EDGAR
2025-02-194Tu Thomas — Chief Medical OfficerGrant/award (A): 7,406 · Code (U): 478,767 · Disposition to issuer (D): 16,599 (derivative) · Disposition to issuer (D): 16,231 (derivative)EDGAR
2025-02-194Strange Kevin T — Chief Financial OfficerCode (U): 67,502 · Disposition to issuer (D): 11,761 (derivative) · Disposition to issuer (D): 5,293 (derivative)EDGAR
2025-02-194Silva Karen — Principal Accounting OfficerCode (U): 14,719EDGAR
2025-02-194Hykes Andrew — President and CEO, DirectorCode (U): 1,550 · Code (U): 1,550 · Code (U): 1,550 · Code (U): 1,000 · Grant/award (A): 20,393 · Code (U): 717,637 · +2 moreEDGAR
2025-02-194Chambers Rebecca — DirectorCode (U): 9,684EDGAR
2025-02-194Szyman Catherine M. — DirectorCode (U): 22,429 · Disposition to issuer (D): 49,719 (derivative)EDGAR
2025-02-194Lucchese Cynthia L — DirectorCode (U): 38,429 · Disposition to issuer (D): 49,719 (derivative)EDGAR
2025-02-194Hoffman William — DirectorCode (U): 238,987EDGAR
2025-02-194MILDER DONALD B — DirectorCode (U): 259,126 · Code (U): 2,831,714EDGAR
2025-02-194ROOT JONATHAN D — DirectorCode (U): 541,149 · Code (U): 335EDGAR
2025-02-194Mead Dana G Jr. — DirectorCode (U): 11,148EDGAR
2025-02-124Hykes Andrew — President and CEO, DirectorOption exercise (M): 161,100 @ $0.43 · Option exercise (M): 16,719 @ $6.45 · Option exercise (M): 16,719 @ $0.46 · Option exercise (M): 161,100 (derivative) @ $0 · Option exercise (M): 16,719 (derivative) @ $0 · Option exercise (M): 16,719 (derivative) @ $0EDGAR
2025-02-124Tu Thomas — Chief Medical OfficerOption exercise (M): 139,584 @ $0.46 · Option exercise (M): 8,420 @ $6.45 · Option exercise (M): 139,584 (derivative) @ $0 · Option exercise (M): 8,420 (derivative) @ $0EDGAR
2025-02-064Hykes Andrew — President and CEO, DirectorGrant/award (A): 67,282 @ $0EDGAR
2025-02-064Strange Kevin T — Chief Financial OfficerGrant/award (A): 21,102 @ $0EDGAR
2025-02-064Tu Thomas — Chief Medical OfficerGrant/award (A): 21,102 @ $0EDGAR
2025-02-064Silva Karen — Principal Accounting OfficerGrant/award (A): 5,504 @ $0EDGAR
2025-01-084Hoffman William — DirectorSale (S): 141,075 @ $60.13 · Sale (S): 58,925 @ $61.27EDGAR
2025-01-034Hykes Andrew — President and CEO, DirectorTax withholding (F): 509 @ $51.05 · Tax withholding (F): 949 @ $51.05 · Tax withholding (F): 1,632 @ $51.05 · Tax withholding (F): 1,319 @ $51.05EDGAR
2025-01-034Strange Kevin T — Chief Financial OfficerTax withholding (F): 63 @ $51.05 · Tax withholding (F): 149 @ $51.05 · Tax withholding (F): 176 @ $51.05 · Tax withholding (F): 227 @ $51.05 · Tax withholding (F): 276 @ $51.05 · Tax withholding (F): 146 @ $51.05EDGAR
2025-01-034Tu Thomas — Chief Medical OfficerTax withholding (F): 337 @ $51.05 · Tax withholding (F): 699 @ $51.05 · Tax withholding (F): 751 @ $51.05 · Tax withholding (F): 516 @ $51.05EDGAR
2025-01-034Hoffman William — DirectorTax withholding (F): 713 @ $51.05 · Tax withholding (F): 1,533 @ $51.05EDGAR
2024-12-204Hykes Andrew — President and CEO, DirectorSale (S): 2,400 @ $55.20 · Sale (S): 600 @ $55.65EDGAR
2024-12-184Hoffman William — DirectorSale (S): 3,176 @ $54.33 · Sale (S): 20,917 @ $55.23 · Sale (S): 13,560 @ $56.45 · Sale (S): 2,347 @ $56.82 · Sale (S): 2,100 @ $54.42 · Sale (S): 10,301 @ $55.27 · +2 moreEDGAR
2024-12-124Tu Thomas — Chief Medical OfficerSale (S): 4,000 @ $55EDGAR
2024-12-034Silva Karen — Principal Accounting OfficerGrant/award (A): 9,215 @ $0EDGAR
2024-11-224Hykes Andrew — President and CEO, DirectorSale (S): 3,000 @ $50.83EDGAR
2024-11-204Hoffman William — DirectorSale (S): 3,000 @ $50.09 · Sale (S): 33,784 @ $51.32 · Sale (S): 3,216 @ $52.11 · Sale (S): 10,250 @ $50.64 · Sale (S): 9,750 @ $51.16EDGAR
2024-10-314Hykes Andrew — President and CEO, DirectorSale (S): 3,000 @ $50EDGAR
2024-10-314Hoffman William — DirectorSale (S): 20,000 @ $50.10 · Sale (S): 20,000 @ $50EDGAR
2024-10-184Hoffman William — DirectorSale (S): 27,804 @ $44.78 · Sale (S): 12,196 @ $45.57EDGAR
2024-10-034Strange Kevin T — Chief Financial OfficerGrant/award (A): 5,695 @ $0 · Tax withholding (F): 268 @ $40.63 · Tax withholding (F): 54 @ $40.63 · Tax withholding (F): 129 @ $40.63 · Tax withholding (F): 152 @ $40.63 · Tax withholding (F): 198 @ $40.63 · +1 moreEDGAR
2024-10-034Tu Thomas — Chief Medical OfficerTax withholding (F): 339 @ $40.63 · Tax withholding (F): 632 @ $40.63 · Tax withholding (F): 679 @ $40.63 · Tax withholding (F): 470 @ $40.63EDGAR
2024-10-034Hykes Andrew — President and CEO, DirectorTax withholding (F): 508 @ $40.63 · Tax withholding (F): 947 @ $40.63 · Tax withholding (F): 1,475 @ $40.63 · Tax withholding (F): 1,292 @ $40.63EDGAR
2024-10-034Hoffman William — DirectorTax withholding (F): 678 @ $40.63 · Tax withholding (F): 1,385 @ $40.63EDGAR
2024-10-024Hill, Mitch C. — Chief Financial OfficerTax withholding (F): 331 @ $40.63 · Tax withholding (F): 616 @ $40.63 · Tax withholding (F): 662 @ $40.63 · Tax withholding (F): 458 @ $40.63EDGAR
2024-09-184Hoffman William — DirectorSale (S): 32,614 @ $45.73 · Sale (S): 7,386 @ $46.27EDGAR
2024-09-134Hill, Mitch C. — Chief Financial OfficerOption exercise (M): 3,000 @ $0.46 · Sale (S): 1,609 @ $44.38 · Sale (S): 891 @ $45.80 · Sale (S): 500 @ $46.34 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2024-08-224Hykes Andrew — President and CEO, DirectorSale (S): 3,000 @ $50EDGAR
2024-08-204Hoffman William — DirectorSale (S): 24,553 @ $48.72 · Sale (S): 15,447 @ $49.17 · Sale (S): 20,000 @ $50.30EDGAR
2024-08-144Hill, Mitch C. — Chief Financial OfficerOption exercise (M): 5,000 @ $0.46 · Sale (S): 4,574 @ $47.94 · Sale (S): 426 @ $48.56 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2024-07-244Hykes Andrew — President and CEO, DirectorSale (S): 3,000 @ $55.23EDGAR
2024-07-184Tu Thomas — Chief Medical OfficerSale (S): 3,480 @ $55.16EDGAR
2024-07-184Hoffman William — DirectorSale (S): 3,404 @ $54.76 · Sale (S): 9,659 @ $55.53 · Sale (S): 8,351 @ $56.58 · Sale (S): 15,974 @ $57.90 · Sale (S): 2,612 @ $58.25 · Sale (S): 1,800 @ $54.70 · +4 moreEDGAR
2024-07-164Hill, Mitch C. — Chief Financial OfficerOption exercise (M): 5,000 @ $0.46 · Sale (S): 3,035 @ $53.72 · Sale (S): 1,965 @ $54.31 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2024-07-164Tu Thomas — Chief Medical OfficerSale (S): 9,920 @ $55.09 · Sale (S): 3,300 @ $55.08 · Sale (S): 3,300 @ $55.10EDGAR
2024-07-034Hill, Mitch C. — Chief Financial OfficerTax withholding (F): 331 @ $50.19 · Tax withholding (F): 616 @ $50.19 · Tax withholding (F): 662 @ $50.19 · Tax withholding (F): 458 @ $50.19EDGAR
2024-07-034Tu Thomas — Chief Medical OfficerTax withholding (F): 339 @ $50.19 · Tax withholding (F): 632 @ $50.19 · Tax withholding (F): 679 @ $50.19 · Tax withholding (F): 470 @ $50.19EDGAR
2024-07-034Hoffman William — DirectorSale (S): 20,000 @ $50.15 · Tax withholding (F): 678 @ $50.19 · Tax withholding (F): 1,385 @ $50.19EDGAR

Recent 8-K events — Inari Medical, Inc.

FiledFormItems reportedSource
2025-02-198-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2025-01-068-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-10-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-07-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-07-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-04-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-04-258-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2024-02-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-238-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2024-01-318-K/A9.01 — Financial Statements and ExhibitsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=NARI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →